
X
Mitsubishi Tanabe pulls ALS drug from EMA assessment
https://pharmaphorum.com/news/mitsubishi-tanabe-pulls-als-drug-from-ema-assessment/
Candidates slow down motor neurone death in patient samples.
FDA asked Mitsubishi to file Radicava following approval in Japan.